Pitfalls of PD-L1 Immunohistochemistry: A Comparison of 22C3 and SP263 antibodies Across Laboratories and Pathologists

被引：0
|
作者：
Wilberger, Adam [1 ]
Aisner, Dara
Merrick, Daniel T. [2 ]
机构：
[1] Univ Colorado Hosp, Aurora, CO USA
[2] Univ Colorado, Boulder, CO 80309 USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2118
引用
收藏
页码：756 / 757
页数：2
相关论文
共 50 条
  • [41] PD-L1 expression in muscle invasive urothelial carcinoma: Comparison of SP142 and SP263 assay
    Gupta, Gurudutt
    Pasricha, Sunil
    Kamboj, Meenakshi
    Sharma, Anila
    Nayana, N. S.
    Durga, Garima
    Sharma, Anurag
    Rawal, Sudhir
    Meh, Anurag
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (04) : 839 - 843
  • [42] Comparison Study of PD-L1 Immunohistochemistry Assays with 22C3 and 28-8: Analysis on Surgical Specimens of NSCLC
    Saito, T.
    Tsuta, K.
    Ishida, M.
    Ryota, H.
    Takeyasu, Y.
    Fukumoto, K.
    Matsui, H.
    Taniguchi, Y.
    Yanagimoto, H.
    Yokoi, T.
    Kurata, T.
    Murakawa, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1816 - S1817
  • [43] Epitope mapping of PD-L1 primary antibodies (28-8, SP142, SP263 E1L3N).
    Schats, Kelly
    Van Vre, Emily A.
    Schrijvers, Darien
    De Meester, Ingrid
    Kockx, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] PD-L1 (22C3) Expression in Primary and Recurrent Glioblastoma
    Arvanitis, Leonidas
    Chen, Hsiao-Wei
    Louie, Carrie
    D'Apuzzo, Massimo
    Gu, Dongqing
    Yew, Hooi
    Portnow, Jana
    Badie, Benham
    Pillai, Raju
    Aoun, Patricia
    Telatar, Milhan
    Afkhami, Michelle
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1600 - 1600
  • [45] PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays
    Munari, Enrico
    Zamboni, Giuseppe
    Lunardi, Gianluigi
    Marconi, Marcella
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Quatrini, Linda
    Vacca, Paola
    Moretta, Lorenzo
    Bogina, Giuseppe
    HUMAN PATHOLOGY, 2019, 90 : 54 - 59
  • [46] PD-L1 (22C3) Expression in Primary and Recurrent Glioblastoma
    Arvanitis, Leonidas
    Chen, Hsiao-Wei
    Louie, Carrie
    D'Apuzzo, Massimo
    Gu, Dongqing
    Yew, Hooi
    Portnow, Jana
    Badie, Benham
    Pillai, Raju
    Aoun, Patricia
    Telatar, Milhan
    Afkhami, Michelle
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1600 - 1600
  • [47] Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms
    Ilie, Marius
    Khambata-Ford, Shirin
    Copie-Bergman, Christiane
    Huang, Lingkang
    Juco, Jonathan
    Hofman, Veronique
    Hofman, Paul
    PLOS ONE, 2017, 12 (08):
  • [48] Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay
    Danziger, Natalie
    Sokol, Ethan S.
    Graf, Ryon P.
    Hiemenz, Matthew C.
    Maule, Jake
    Parimi, Vamsi
    Palmieri, Carlo
    Pusztai, Lajos
    Ross, Jeffrey S.
    Huang, Richard S. P.
    ONCOLOGIST, 2023, : 319 - 326
  • [49] Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N
    Jacquelyn Smith
    Mark D. Robida
    Krista Acosta
    Bharathi Vennapusa
    Amita Mistry
    Greg Martin
    Alton Yates
    H. James Hnatyszyn
    Diagnostic Pathology, 11
  • [50] Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast Carcinoma
    Huang, Xiao
    Anderson, Sarah A.
    Siegal, Gene P.
    Wei, Shi
    Liu, Shanrun
    Yang, Jingyun
    Roisin, Puentes
    Pickens, J. Taylor
    Huo, Lei
    Sahin, Aysegul A.
    Granada, Carlos Prieto
    Chen, Shuojun
    CLINICAL BREAST CANCER, 2024, 24 (04) : e310 - e318
12345